Cargando…

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas

BACKGROUND: Although intrinsic immune-evasion is important in cancer proliferation, metastasis and response to treatment, it is unclear whether intrinsic immune-evasion patterns of gliomas can aid in predicting clinical prognosis and determining treatment. METHODS: A total of 182 immune-evasion gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Zewei, Ji, Qiankun, Han, Qing, Long, Xiaoyan, Li, Jingying, Wu, Lei, Huang, Kai, Zhu, Xingen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465887/ https://www.ncbi.nlm.nih.gov/pubmed/36096781 http://dx.doi.org/10.1186/s12885-022-09984-5

Ejemplares similares

Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity
por: Tu, Zewei, et al.
Publicado: (2022)

CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
por: Jiang, Yuan, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas
por: Ji, Qiankun, et al.
Publicado: (2022)

Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas
por: Liu, Junzhe, et al.
Publicado: (2022)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas
por: Fang, Zhansheng, et al.
Publicado: (2022)

Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
por: Lei, Kunjian, et al.
Publicado: (2021)

Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis
por: Tu, Zewei, et al.
Publicado: (2022)

Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively
por: Tu, Zewei, et al.
Publicado: (2022)

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2020)

Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
por: Tu, Zewei, et al.
Publicado: (2023)

Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma
por: Luo, Haitao, et al.
Publicado: (2021)

DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients
por: Liu, Feng, et al.
Publicado: (2022)

A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2021)

Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma
por: Tu, Zewei, et al.
Publicado: (2021)

Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV
por: McDuff, Susan G. R., et al.
Publicado: (2019)

Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)

Human Mitochondrial Ribosomal RNA Modification-Based Classification Contributes to Discriminate the Prognosis and Immunotherapy Response of Glioma Patients
por: Wang, Peng, et al.
Publicado: (2021)

Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients
por: Hu, Yan, et al.
Publicado: (2021)

A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
por: Wan, Yanzhi, et al.
Publicado: (2023)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Depatux-M and temozolomide in advanced high-grade glioma
por: Hirsch, Sophie, et al.
Publicado: (2020)

Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma
por: Wang, Peng, et al.
Publicado: (2020)

Nidogen-1 expression is associated with overall survival and temozolomide sensitivity in low-grade glioma patients
por: Zhang, Baiwei, et al.
Publicado: (2021)

Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy
por: Li, Kuangxun, et al.
Publicado: (2021)

Ferroptosis in tumor immunity and therapy
por: Gong, Chuandong, et al.
Publicado: (2022)

Temozolomide in paediatric high-grade glioma: a key for combination therapy?
por: Verschuur, A C, et al.
Publicado: (2004)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies
por: Liu, Hao, et al.
Publicado: (2023)

Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells
por: Liang, Ping, et al.
Publicado: (2016)

Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy
por: Murphy, P S, et al.
Publicado: (2004)

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2016)

Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi, Hui, et al.
Publicado: (2020)

Development of a prognostic index based on immunogenomic landscape analysis in glioma
por: Luo, Haitao, et al.
Publicado: (2021)

Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
por: Tu, Zewei, et al.
Publicado: (2023)

Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas
por: Ye, Wenrui, et al.
Publicado: (2021)

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

Comprehensive analysis of the prognostic implications and functional exploration of PAK gene family in human cancer
por: Lei, Kunjian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lu2790msj49j982lq9ov5lv76j